OREANDA-NEWS. September 02, 2011. SANITAS AB received a notification from shareholder Valeant Pharmaceuticals International, Inc. about the decision of the Securities Commission of the Republic of Lithuania to approve the circular of a non-competitive mandatory tender offer to buy up the remaining ordinary registered voting shares of SANITAS AB.

The tender offer price is EUR 10.06 per 1 (one) ordinary registered share of SANITAS AB, LTL 1 (one litas) par value (ISIN code LT0000106171) each (equivalent in litas is equal to LTL 34.74). Commencement of the implementation of the tender offer is on 2 September 2011, termination – on 15 September 2011.

Comprehensive conditions of the tender offer are presented in the circular attached (please see the annex).

A person authorized to provide additional information: Mr. Saulius Jurgelenas, Chief Executive Officer of SANITAS AB phone number +370 686 67779.